keyword
https://read.qxmd.com/read/38587978/restricted-access-and-advanced-disease-in-post-pandemic-testicular-cancer
#21
JOURNAL ARTICLE
Mitchell Fagan, W C Ian Janes, Matthew Andrews, David R Harvey, Geoff M Warden, Michael K Organ, Paul Johnston
INTRODUCTION: Urologists observed reduced cancer consultations and surgeries during the SARS-CoV-2 pandemic, raising concern about treatment delays. Testicular cancer serves as a particularly sensitive marker of this phenomenon, as the clinical stage of testicular cancer at presentation is predictive of cancer-specific survival. We aimed to investigate whether COVID-related restrictions to primary care access resulted in increased incidence of metastatic germ cell testis cancer. METHODS: A retrospective chart review was conducted on all cases of testicular cancer managed surgically at our center from March 1, 2018, to February 28, 2023...
April 2, 2024: Canadian Urological Association Journal
https://read.qxmd.com/read/38584332/ovarian-sex-cord-tumor-harboring-fus-crem-fusion-an-ovarian-counterpart-of-inflammatory-and-nested-testicular-sex-cord-tumor
#22
JOURNAL ARTICLE
Thomas M Ulbright, Andrés M Acosta
No abstract text is available yet for this article.
April 8, 2024: American Journal of Surgical Pathology
https://read.qxmd.com/read/38575837/fertility-preservation-in-hematological-cancer-patients
#23
REVIEW
Dan Li, Yi-Jun Zhao, Qian Wang, Man-Wei Chu, Juan-Ke Xie, Cui-Lian Zhang
Among adolescents and young adults, hematological malignancies are the most common malignancies. Although the survival rate of hematological malignancies in young patients has been dramatically improved, due to the continuous improvement and development of tumor diagnosis and treatment options, cytotoxic therapies can significantly reduce a patient's reproductive capacity and cause irreversible infertility. The most two established solutions are embryo cryopreservation and oocyte cryopreservation which can be considered in single female...
April 4, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38572155/a-poor-prognostic-male-choriocarcinoma-with-multiple-systemic-metastases-a-case-report-and-the-literature-review
#24
Wenpeng Huang, Zuohuan Zheng, Zheng Bao, Xiaoyan Xiao, Liming Li, Zhaonan Sun, Lei Kang
BACKGROUND: Non-gestational choriocarcinoma, also known as primary choriocarcinoma, is extremely rare in men, manifesting with specific signs such as breast feminization, testicular atrophy, and loss of libido. The presentation typically includes elevated serum β-hCG levels, widespread metastatic disease, and a rapid progression of the condition. CASE REPORT: We present a rare case of a 41-year-old man diagnosed with choriocarcinoma, exhibiting a unique combination of multiple metastases, including lung, brain, bone, and retroperitoneal lymph node metastases, as confirmed by 18 F-FDG PET/CT imaging...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38571873/rhabdomyosarcoma-in-adults-de-novo-or-conversion-from-non-seminomas
#25
Moutaz Ghrewati, Anas Mahmoud, Tala Beliani, Mehandar Kumar
Rhabdomyosarcoma (RMS) is a highly sporadic, very aggressive, and fatal soft tissue tumor in adults. Although more common and treatable in the pediatric population, the occurrence of pleomorphic RMS in adults has a low incidence. Hence, it is not easy to treat. Surgery is the primary definitive treatment, along with radiation therapy, while adjuvant chemotherapy has recently gained popularity. We present an infrequent case of RMS in a patient with a recent history of mixed non-seminomatous germ-cell tumor testicular cancer...
March 2024: Curēus
https://read.qxmd.com/read/38568330/-testicular-tumor-in-a%C3%A2-9-year-old-boy
#26
JOURNAL ARTICLE
Abhay Raiyani, M Borisenkov, A Pandey
A 9-year-old boy presented to the emergency department after noticing a painless mass on the right testicle during self-examination in the shower. On physical examination, both testes were mobile and painless, with the right testis twice as big as the left and exhibiting palpable resistance. Sonographic examination revealed a uniformly demarcated mass with a ventral protrusion on the right testis. Tumor markers and blood tests were normal. The testis was exposed inguinally and the tumor was enucleated, which revealed a dermoid cyst...
April 3, 2024: Urologie
https://read.qxmd.com/read/38562579/epidermoid-cyst-of-the-testis-a-report-of-three-cases
#27
Kimitsugu Usui, Ryo Yamashita, Yuma Sakura, Masafumi Nakamura, Hideo Shinsaka, Masato Matsuzaki, Masashi Niwakawa
Testicular epidermoid cysts have characteristic findings. Testicular tumor markers are negative in patients with epidermoid cysts. Clear margins and sole and small testicular tumors (20 mm or less) suggest the possibility of epidermoid cyst. Testicular-sparing surgery with intraoperative frozen section examination should be performed when suspecting epidermoid cysts. Testicular epidermoid cysts are rare tumors that account for 1% of all testicular tumors and are often clinically misdiagnosed as malignant lesions...
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38555680/chemotherapy-induced-peripheral-neuropathy-cipn-as-a-predictor-of-decreased-quality-of-life-in-testicular-germ-cell-tumor-survivors
#28
JOURNAL ARTICLE
Zuzana Orszaghova, Dominika Galikova, Peter Lesko, Jana Obertova, Katarina Rejlekova, Zuzana Sycova-Mila, Patrik Palacka, Katarina Kalavska, Daniela Svetlovska, Beata Mladosievicova, Jozef Mardiak, Michal Mego, Michal Chovanec
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) after curative treatment for testicular germ cell tumors (GCTs) has been previously reported. It has been shown that CIPN can contribute to impaired quality of life (QOL) in cancer survivors. Herein, we aimed to evaluate CIPN in association with QOL in GCT survivors. PATIENTS AND METHODS: European Organization for Research and Treatment of Cancer (EORTC) Quality of Life - Chemotherapy-Induced Peripheral Neuropathy questionnaire (QLQ-CIPN20) and Quality of Life Questionnaire (QLQ-C30) were prospectively completed by GCT survivors (N = 151) at National Cancer Institute in Slovakia during their annual follow-up...
March 2, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38552418/clinical-outcomes-after-inferior-vena-cava-resection-for-malignant-disease-a-single-center-experience-of-51-vena-cava-resections
#29
JOURNAL ARTICLE
Lucas De Crignis, Mathias Guesnon, Axel Morin, Ivan Aleksic, Michel Rivoire, Pierre Meeus, Aurélien Dupré, Patrice Peyrat
BACKGROUND AND OBJECTIVE: For tumors involving inferior vena cava (IVC), surgery with complete resection remains the first line treatment. Management of IVC after resection, either ligation without reconstruction or primary reconstruction, is debated. Our study aimed to evaluate type of venous reconstruction, anticoagulation management and morbidity. METHODS: A French single center database of patients who underwent partial or total circumferencial resection of the IVC for malignant disease was analyzed...
March 7, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38542123/downregulation-of-serotonergic-system-components-in-an-experimentally-induced-cryptorchidism-in-rabbits
#30
JOURNAL ARTICLE
Francisco Jiménez-Trejo, Cristian Arriaga-Canon, Luis A Herrera, Isabel Coronado-Mares, Rogelio Montiel-Manríquez, Isaac González-Santoyo, Wendy B Pérez-Báez, Miguel Tapia-Rodríguez
Cryptorchidism (CO) or undescended testes is defined as the failure of one or both testes to be positioned inside the scrotum. Typically, cryptorchidism is detected at birth or shortly thereafter, and in humans, it is considered to be part of the testicular dysgenesis syndrome (TDS), a complex pathology regarding the male reproductive system that apparently involves the interaction of both genetic and environmental harmful factors, mainly during embryonic development. Serotonin (5-HT) is an ancient molecule that participates in a broad range of body functions, and in recent years, its importance in reproduction has started to be elucidated...
March 9, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38541782/expression-of-immunotherapy-target-prame-in-cancer-correlates-with-histone-h3-acetylation-and-is-unrelated-to-expression-of-methylating-dmnt3a-3b-and-demethylating-tet1-enzymes
#31
JOURNAL ARTICLE
Maciej Kaczorowski, Jerzy Lasota, Krzysztof Dudek, Bartosz Małkiewicz, Markku Miettinen, Agnieszka Hałoń
Background/Objectives: Preferentially expressed antigen in melanoma (PRAME), a member of the cancer testis antigen family, is a promising target for cancer immunotherapy. Understanding the epigenetic mechanisms involved in the regulation of PRAME expression might be crucial for optimizing anti-PRAME treatments. Methods: Three malignancies of different lineages (sinonasal melanoma, testicular seminoma, and synovial sarcoma), in which immunohistochemical (IHC) reactivity for PRAME is a common yet variable feature, were studied...
March 8, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38541652/ras-mitogen-activated-protein-kinase-signaling-pathway-in-testicular-germ-cell-tumors
#32
REVIEW
Angelo Onorato, Eugenia Guida, Ambra Colopi, Susanna Dolci, Paola Grimaldi
Germ cell tumors (GCTs) are relatively rare tumors. However, they are the most diagnosed malignancies occurring in the testis among men aged between 15 and 40 years. Despite high aneuploidy and a paucity of somatic mutations, several genomic and transcriptomic assays have identified a few significantly mutated somatic genes, primarily KIT and K-RAS. The receptor Tyrosine Kinase (RTK) pathway and the downstream related Mitogen-Activated Protein Kinase (MAPK) cascades are crucial signal transduction pathways that preside over various cellular processes, including proliferation, differentiation, apoptosis, and responses to stressors...
February 29, 2024: Life
https://read.qxmd.com/read/38532895/cryptorchidism-and-puberty
#33
REVIEW
Wiwat Rodprasert, Helena E Virtanen, Jorma Toppari
Cryptorchidism is the condition in which one or both testes have not descended adequately into the scrotum. The congenital form of cryptorchidism is one of the most prevalent urogenital anomalies in male newborns. In the acquired form of cryptorchidism, the testis that was previously descended normally is no longer located in the scrotum. Cryptorchidism is associated with an increased risk of infertility and testicular germ cell tumors. However, data on pubertal progression are less well-established because of the limited number of studies...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38531266/prognostic-factors-for-relapse-in-patients-with-clinical-stage-i-testicular-non-seminoma-a-nationwide-population-based-cohort-study
#34
JOURNAL ARTICLE
Thomas Wagner, Birgitte Grønkær Toft, Jakob Lauritsen, Mikkel Bandak, Ib Jarle Christensen, Birte Engvad, Michael Kreiberg, Mads Agerbæk, Lars Dysager, Andreas Carus, Josephine Julie Rosenvilde, Daniel Berney, Gedske Daugaard
BACKGROUND: Approximately 30% of patients with clinical stage I non-seminoma (CSI-NS) relapse. Current risk stratification is based on lymphovascular invasion (LVI) alone. The extent to which additional tumor characteristics can improve risk prediction remains unclear. OBJECTIVE: To determine the most important prognostic factors for relapse in CSI-NS patients. DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study including all patients with CSI-NS diagnosed in Denmark between 2013 and 2018 with follow-up until 2022...
March 17, 2024: European Journal of Cancer
https://read.qxmd.com/read/38527609/protective-effect-of-dental-pulp-stem-cells-conditioned-medium-against-cisplatin-induced-testicular-damage-in-rats
#35
JOURNAL ARTICLE
Afsaneh Hokmabadi, Esmaeil Ranjbar, Fatemeh Alipour, Alireza Ebrahimzadeh-Bideskan, Jalil Tavakol Afshari, Mohammad Morteza Rezaei, Reyhaneh Shafieian
Cisplatin is a highly effective chemotherapy drug used to treat most solid tumors. However, one of its side effects is testicular toxicity, which can lead to fertility abnormalities. This study investigated the effectiveness of dental pulp mesenchymal stem cells conditioned medium (DPSC-CM) on cisplatin-induced testicular toxicity. In this study, 36 eight-week-old male Wistar rats were randomly divided into three groups equally (n = 12). Group 1 control "CTR", which received normal saline (0.5ml) intraperitoneally (i...
March 23, 2024: Toxicology
https://read.qxmd.com/read/38525515/evolution-of-testicular-germ-cell-tumors-in-the-molecular-era-with-histogenetic-implications
#36
JOURNAL ARTICLE
Irem Kilic, Andres M Acosta, Muhammad T Idrees
The current WHO classification of testicular germ cell tumors is based on the pathogenesis of the tumors driven by different genomic events. The germ cell neoplasia in situ is the precursor lesion for all malignant germ cell tumors. The current understanding of pathogenesis is that the developmental and environmental factors with the erasure of parental genomic imprinting lead to the development of abnormal gonocytes that settle in the "spermatogonial Niche" in seminiferous tubules. The abnormal primordial germ cells in the seminiferous tubules give rise to pre-GCNIS cells under the influence of TPSY and OCT4 genes...
March 25, 2024: Advances in Anatomic Pathology
https://read.qxmd.com/read/38524218/association-of-the-minimal-cyclophosphamide-equivalent-dose-and-outcome-of-microdissection-testicular-sperm-extraction-in-patients-with-persistent-azoospermia-after-chemotherapy
#37
JOURNAL ARTICLE
I-Shen Huang, Richard J Fantus, Joshua A Halpern, James Wren, Nelson E Bennett, Minh Nguyen Pham, Alexander Stanisic, William J Huang, Robert E Brannigan
OBJECTIVE: To investigate whether the minimal cyclophosphamide equivalent dose (mCED), a novel approach for estimating alkylating agent exposure, is associated with the sperm retrieval rates by microdissection testicular sperm extraction (mTESE) in azoospermic postchemotherapy cancer survivors. DESIGN: A retrospective cohort study conducted between 2002 and 2017. SETTING: An academic medical center. PATIENTS: A total of 28 azoospermic postchemotherapy cancer survivors who underwent mTESE...
March 2024: F&S reports
https://read.qxmd.com/read/38514050/large-malignant-testicular-paratesticular-tumors-in-adolescence-assessment-of-gross-tumor-size-in-a-vulnerable-age-group
#38
JOURNAL ARTICLE
Ava G Stechschulte, Andrea C Bakker, Jasmine Steele, Sara O Vargas
OBJECTIVE: We hypothesized that reticence to address a groin mass may result in late presentation of testicular/paratesticular malignancy in early puberty through adolescence. METHODS: Malignant testicular and paratesticular tumors (malignant germ cell tumors and rhabdomyosarcomas) diagnosed at our institution from 1994-2023 for patients aged 11-20 were included. Clinicopathologic features were recorded, and statistically analyzed. RESULTS: Eighty-five cases were identified...
March 21, 2024: Annals of Clinical and Laboratory Science
https://read.qxmd.com/read/38513186/increasing-annual-cancer-incidence-in-patients-age-20-49-years-a-real-data-study
#39
JOURNAL ARTICLE
Nuria Ribelles, Javier Pascual, Laura Galvez-Carvajal, Sofía Ruiz-Medina, Javier Garcia-Corbacho, Jose Carlos Benitez, Maria Emilia Dominguez-Recio, Esperanza Torres, Lucia Oliva, Manuel Zalabardo, Antonio Rueda, Emilio Alba
PURPOSE: Data from population-based studies have shown an increased incidence of certain types of neoplasms in patients younger than 50 years (early-onset cancer [EOC]); however, little information is derived from other real-world data sources. In a nonpopulation registry, we analyzed changes in the incidence of several neoplasms in successive generations. METHODS: This cross-sectional study included all patients with a cancer diagnosis registered in one university hospital in Málaga, Spain, between 1998 and 2021, and 18 neoplasms were analyzed...
March 2024: JCO global oncology
https://read.qxmd.com/read/38511018/primary-testicular-mucinous-adenocarcinoma-a-case-report-and-review-of-literature
#40
Vijayabhaskar Ramakrishnan, Kirushna Kumar, Krishna Kumar Rathnam, Thalabathik Kumara Vikram, Niranjana Devi, Arul
Testicular tumors include germ cell tumors, sex cord stromal tumors, and ovarian type epithelial tumors. Testicular mucinous tumors belong to ovarian type epithelial tumors and are extremely rare with only 31 cases reported in literature so far. Among those, mucinous adenocarcinoma constitutes only 9 cases. There are no standard treatment guidelines owing to their rarity. We report a case of primary testicular mucinous adenocarcinoma managed by orchidectomy, chemotherapy, and retroperitoneal lymph node dissection...
March 2024: Indian Journal of Surgical Oncology
keyword
keyword
71482
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.